Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Biosplice Publishes Phase 2B Lorecivivint Analysis Showing Clinically Meaningful Benefits to Knee Osteoarthritis Patients

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  Biosplice Therapeutics, Inc.

EssilorLuxottica : EssilorLuxottica challenges the decision of the French Competition Authority (FCA) against Luxottica

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  EssilorLuxottica

Gelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer

Read more ››
By: GlobenewsWire - 22 Jul 2021

Southern Ontario Nature Coalition Calls for Protecting Nature in Canada’s Near-Urban Areas 

Read more ››
By: GlobenewsWire - 22 Jul 2021

Trigone Pharma to Present Preclinical Data for TRG-100 in Interstitial Cystitis / Bladder Pain Syndrome at the Upcoming American Urological Association Conference (AUA) in September 2021

Read more ››
By: GlobenewsWire - 22 Jul 2021

Virbac : Declaration of the number of shares and voting rights June 2021

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  Virbac

Foresight Diagnostics’ PhasED-Seq Circulating Tumor DNA Platform Demonstrates Highly Sensitive Minimal Residual Disease (MRD) Detection in B-Cell Lymphomas

Read more ››
By: GlobenewsWire - 22 Jul 2021

Guerbet: Revenue at June 30, 2021

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  Global Blood Therapeutics Inc. | Guerbet SA

Sanofi: Information concerning the total number of voting rights and shares - June 2021

Read more ››
By: GlobenewsWire - 22 Jul 2021

AB Science today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC)

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  AB Science SA | AllianceBernstein L.P.

Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund

Read more ››
By: GlobenewsWire - 22 Jul 2021
Related companies:  Chembio Diagnostics, Inc.

Belgium sends emergency aid to Tunisia in the fight against COVID-19

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021

Cureduchenne Launches Innovative Supplemental Newborn Screening Initiative Offering Opportunity for Early Diagnosis of Rare, Fatal Disease

Brigham and Women's Hospital Becomes Only US Birth Hospital with a Program Offering Parents a Choice to Have Supplemental Newborn Screening for Duchenne Muscular Dystrophy Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021
Related companies:  CureDuchenne | CureDuchenne Ventures, LLC

LongueVue Capital Successfully Exits Zavation Medical Products, a Leading Spinal Implant Platform

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021

Valo Health to Participate in SVB Leerink CybeRx Conference: Big Data, A.I. & Machine Learning in Healthcare

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021
Related companies:  Valo Health, LLC

Qure4u Announces Close of $25M Growth Equity Investment to Accelerate Innovation in Digital Health Solutions

Qure4u's funding from Volition Capital comes on the heels of record growth bolstered by strong management and rapid industry adoption of the company's complete digital health platform Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021

EDCare Kansas City Introduces New Adolescent Treatment Program

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021

Inhalon Collaborates with Celltrion, Inc. to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home

Topline Results Expected in 2022;Phase 1/2a Studies Funded by U.S. Army Medical Research & Development Command Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021
Related companies:  Inhalon Biopharma, Inc.

Paradigm Appoints Elizabeth Ulloa Lowry as Senior Vice President of Case Management

Proven 20-year Workers' Compensation Industry Leader Heralds Growth and Innovation for Paradigm's Case Management Solutions Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021
Related companies:  Paradigm BioDevices, Inc. | Paradigm Shift Therapeutics

EOM Pharmaceuticals Appoints Drug Development Veteran Frank L. Douglas, Ph.D., M.D., Scientific Advisor

Dr. Douglas Brings Over 30 Years of Successful Drug Development Experience to EOM and will Chair EOM's Scientific Advisory Board, Leading Development of EOM613 Read more ››
By: PR Newswire Association LLC. - 22 Jul 2021
Related companies:  EOM Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑